Scinai Immunotherapeutics Ltd (SCNI) — Working Capital to Net Assets Ratio
Scinai Immunotherapeutics Ltd (SCNI) has a Working Capital to Net Assets ratio of -7.8% as of June 2025. Working capital of $-614.00K (current assets of $1.51 Million minus current liabilities of $2.12 Million) is measured against net assets of $7.86 Million. A higher ratio indicates strong short-term liquidity financed by the equity base. See SCNI equity financing ratio to measure how much of total assets are equity-financed.
WC/NA Ratio
Working Capital
Current Assets
Current Liabilities
Scinai Immunotherapeutics Ltd Working Capital to Net Assets (2008–2024)
This chart shows how Scinai Immunotherapeutics Ltd's Working Capital to Net Assets ratio has evolved across 17 annual periods from 2008 to 2024. As of June 2025, the ratio stands at -7.8%, reflecting working capital of $-614.00K against net assets of $7.86 Million USD. Check tangible net worth ratio of Scinai Immunotherapeutics Ltd to evaluate the tangible quality of the company's equity base.
Annual Working Capital to Net Assets for Scinai Immunotherapeutics Ltd (2008–2024)
The table below presents the year-by-year Working Capital to Net Assets ratio for Scinai Immunotherapeutics Ltd from 2008 to 2024, covering 17 annual filings. Each row shows current assets, current liabilities, working capital, net assets, the ratio, and the change in percentage points compared to the prior year. For live market cap and the full company profile, see SCNI stock market capitalisation.
| Year | WC/NA Ratio | Working Capital (USD) | Net Assets | Current Assets | Current Liabilities | Change (pp) |
|---|---|---|---|---|---|---|
| 2024 | 5.9% | $585.00K | $9.98 Million | $2.39 Million | $1.81 Million | ▲ +86.1 pp |
| 2023 | -80.3% | $3.67 Million | $-4.57 Million | $5.45 Million | $1.78 Million | ▲ +603.4 pp |
| 2022 | -683.6% | $12.03 Million | $-1.76 Million | $14.37 Million | $2.34 Million | ▼ -2251.8 pp |
| 2021 | 1568.1% | $15.40 Million | $982.00K | $17.84 Million | $2.44 Million | ▲ +1201.1 pp |
| 2020 | 367.0% | $-16.67 Million | $-4.54 Million | $3.31 Million | $19.97 Million | ▲ +450.2 pp |
| 2019 | -83.3% | $15.68 Million | $-18.84 Million | $21.17 Million | $5.49 Million | ▲ +93.1 pp |
| 2018 | -176.4% | $14.72 Million | $-8.35 Million | $20.55 Million | $5.83 Million | ▼ -298.0 pp |
| 2017 | 121.6% | $19.66 Million | $16.17 Million | $21.64 Million | $1.98 Million | ▲ +25.0 pp |
| 2016 | 96.7% | $6.43 Million | $6.65 Million | $6.78 Million | $356.88K | ▼ -8.3 pp |
| 2015 | 105.0% | $9.04 Million | $8.61 Million | $9.48 Million | $436.03K | ▲ +39.3 pp |
| 2014 | 65.7% | $2.80 Million | $4.26 Million | $3.26 Million | $465.31K | ▼ -11.8 pp |
| 2013 | 77.5% | $5.36 Million | $6.92 Million | $5.87 Million | $513.90K | ▲ +6.2 pp |
| 2012 | 71.3% | $4.24 Million | $5.95 Million | $4.50 Million | $259.71K | ▼ -2.6 pp |
| 2011 | 74.0% | $4.96 Million | $6.71 Million | $5.40 Million | $439.88K | ▼ -9.7 pp |
| 2010 | 83.7% | $6.64 Million | $7.94 Million | $7.37 Million | $732.18K | ▼ -7.7 pp |
| 2009 | 91.4% | $7.71 Million | $8.44 Million | $8.21 Million | $505.28K | ▼ -2.0 pp |
| 2008 | 93.3% | $2.80 Million | $3.00 Million | $2.99 Million | $192.22K | — |